Serum osteoprotegerin and carotid intima-media thickness in acute/chronic coronary artery diseases

Journal of Cardiovascular Medicine

Volumn 14, Issue 1, 2013, Pages 43-48

  Ciccone, Marco M ^a   Scicchitano, Pietro ^a   Gesualdo, Michele ^a   Zito, Annapaola ^a   Carbonara, Rosa ^a   Locorotondo, Manuela ^a   Mandurino, Cosimo ^a   Masi, Filippo ^a   Boccalini, Francesca ^b   Lepera, Mario E ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

acute coronary syndrome; cardiovascular risk; common carotid intima media thickness; coronary artery disease; osteoprotegerin

Indexed keywords

OSTEOPROTEGERIN;

ACUTE CORONARY SYNDROME; AGE; AGED; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CHRONIC DISEASE; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; THORAX PAIN;

ACUTE CORONARY SYNDROME; AGED; CAROTID INTIMA-MEDIA THICKNESS; CHRONIC DISEASE; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; RISK FACTORS;

EID: 84871948974     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283561433     Document Type: Article

References (35)

1. De Pergola G, Ciccone MM, Guida P, et al. Relationship between C3 Levels and common carotid intima-media thickness in overweight and obese patients. Obes Facts 2011; 4:159-163.
2. Giansante C, Fiotti N, Di Chiara A, et al. In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers. J Cardiovasc Med (Hagerstown) 2007; 8:602-607. (Pubitemid 47222174)
3. Doherty TM, Asotra K, Fitzpatrick LA, et al. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci USA 2003; 100:11201-11206. (Pubitemid 37205912)
4. Sandberg WJ, Yndestad, Øie E, et al. Enhanced T-cell expression of RANK ligand in acute coronary syndrome. Possible role in plaque destabilization. Arterioscler Thromb Vasc Biol 2006; 26:857-863. (Pubitemid 43732163)
5. Jono S, Ikari Y, Shioi A, et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 2002; 106:1192-1194. (Pubitemid 34988634)
6. Schoppet M, Sattler AM, Schaefer JR, Herzum M, Maisch B, Hofbauer LC. Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab 2003; 88:1024-1028. (Pubitemid 36337751)
7. Gannagé-Yared MH, Fares F, Semaan M, Khalife S, Jambart S. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population. Clin Endocrinol 2006; 64:65.
8. Ciccone MM, Marzullo A, Mizio D, et al. Can carotid plaque histology selectively predict the risk of an acute coronary syndrome? Int Heart J 2011; 52:72-77.
9. Ciccone MM, Balbarini A, Porcelli MT, et al. Carotid artery intima-media thickness: normal and percentile values in the Italian population (CAMP study). Eur J Cardiovasc Prev Rehabil 2011; 18:650-655.
10. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/NSTEMI: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/NSTEMI) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007; 50:e1-e157.
11. Fraker TD Jr, Fihn SD, Gibbons RJ, et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 2007; 50:2264-2274. (Pubitemid 350166813)
12. Silber S, Albertsson P, Avilés FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26:804-847.
13. Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25:1751-1762. (Pubitemid 47356612)
14. (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-3421.
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33:S62-S69.
16. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74:1399-1406. (Pubitemid 17189260)
17. Siepi D, Marchesi S, Vaudo G, et al. Preclinical vascular damage in white postmenopausal women: the relevance of osteoprotegerin. Metabolism 2008; 57:321-325. (Pubitemid 351178720)
18. Lieb W, Gona P, Larson MG, et al. Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality. Arterioscler Thromb Vasc Biol 2010; 30:1849-1854.
19. Sandberg WJ, Yndestad A, Øie E, et al. Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization. Arterioscler Thromb Vasc Biol 2006; 26:857-863. (Pubitemid 43732163)
20. Golledge J, McCann M, Mangan S, Lam A, Karan M. Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. Stroke 2004; 35:1636-1641. (Pubitemid 38823639)
21. Jensen JK, Ueland T, Atar D, et al. Osteoprotegerin concentrations and prognosis in acute ischaemic stroke. J Intern Med 2009; 267:410-417.
22. Omland T, Ueland T, Jansson AM, et al. Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes. J Am Coll Cardiol 2008; 51:627-633. (Pubitemid 351193104)
23. Nybo M, Johnsen SP, Dethlefsen C, et al. Lack of observed association between high plasma osteoprotegerin concentrations and ischemic stroke risk in a healthy population. Clin Chem 2008; 54:1969-1974. (Pubitemid 352774029)
24. Nybo M, Johnsen SP, Dethlefsen C, et al. Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003. Arterioscler Thromb Vasc Biol 2009; 29:975-980.
25. Caidahl K, Ueland T, Aukrust P. Osteoprotegerin: a biomarker with many faces. Arterioscler Thromb Vasc Biol 2010; 30:1684-1686.
26. Schoppet M, Preissner KT, Hofbauer LC. RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol 2002; 22:549-553. (Pubitemid 34408732)
27. Rennenberg RJ, Schurgers LJ, Kroon AA, Stehouwer CD. Arterial calcifications. J Cell Mol Med 2010; 14:2203-2210.
28. Vik A, Mathiesen EB, Johnsen SH, et al. Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population: the Tromsø study. J Thromb Haemost 2010; 8:898-905.
29. Akinci B, Demir T, Celtik A, et al. Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes. Diabetes Res Clin Pract 2008; 82:172-178.
30. Vik A, Mathiesen EB, Brox J, et al. Relation between serum osteoprotegerin and carotid intima media thickness in a general population: the Tromsø Study. J Thromb Haemost 2010; 8:2133-2139.
31. Cicorella N, Zanolla L, Franceschini L, et al. Usefulness of ultrasonographic markers of carotid atherosclerosis (intima-media thickness, unstable carotid plaques and severe carotid stenosis) for predicting presence and extent of coronary artery disease. J Cardiovasc Med (Hagerstown) 2009; 10:906-912.
32. Anand DV, Lahiri A, Lim E, Hopkins D, Corder R. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. JACC 2006; 47:1850-1857.
33. Pedersen ER, Ueland T, Seifert R, et al. Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris. Atherosclerosis 2010; 212:644-649.
34. Quercioli A, Montecucco F, Bertolotto M, et al. Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling. Eur J Clin Invest 2010; 40:645-654.
35. Crisafulli A, Micari A, Altavilla D, et al. Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction. Clin Sci 2005; 109:389-395. (Pubitemid 41445246)